IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 6450 participants.
Also called NCT06118840
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 6,450 participants
- Sponsor
- Registry
-
NCT06118840
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06118840. Randomized; quadruple masking; primary purpose diagnostic. Start 2024-05-20 (actual); primary completion 2026-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
- Acronym
- IDEAL
- Condition
- Intracranial Aneurysm
- Condition
- CT Angiography
- Condition
- Deep Learning
- Condition
- Double Bind Interaction
- Intervention (Device)
- True-AI-integrated intracranial aneurysms diagnosis strategy
- Intervention (Device)
- Sham-AI-integrated intracranial aneurysms diagnosis strategy
- Lead sponsor
- Jinling Hospital, China
Record details
- Record id
cardio:ct-nct06118840- Content hash
7bf0defb8dceb040aaf194ab52906f2e8bb99e61391bef7063f0669c9a5f651e